{{Rsnum
|rsid=2054399
|Gene=KCNMB2
|Chromosome=3
|position=178623794
|Orientation=plus
|GMAF=0.3421
|Gene_s=KCNMB2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.1 | 51.4 | 38.5
| HCB | 25.8 | 47.7 | 26.5
| JPT | 29.4 | 39.4 | 31.2
| YRI | 0.7 | 21.1 | 78.2
| ASW | 3.6 | 33.9 | 62.5
| CHB | 25.8 | 47.7 | 26.5
| CHD | 21.5 | 48.6 | 29.9
| GIH | 5.0 | 34.7 | 60.4
| LWK | 0.9 | 25.9 | 73.1
| MEX | 10.7 | 42.9 | 46.4
| MKK | 3.4 | 32.2 | 64.4
| TSI | 14.9 | 39.6 | 45.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=0.000001
|OR=1.2200
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}